All In MedTech

FDA Clearance Tracker · P970008-S015

UROLOGIX TARGIS SYSTEM CONTROL UNIT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 6, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 6, 2001

Approved

Time to decision

379 days

Received Nov 22, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970008-S015
Device name
UROLOGIX TARGIS SYSTEM CONTROL UNIT
Applicant
Urologix, LLC
Applicant location
Plymouth, MN
Received
Nov 22, 2000
Decided
Dec 6, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P970008

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT COLORADO MEDTECH, LONGMONT, COLORADO.

Source documents

Other decisions for Urologix, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.